{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:11:48Z","timestamp":1785773508586,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.4158\/ep.9.5.400","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:45:07Z","timestamp":1365205507000},"page":"400-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Asymptomatic Primary Hyperparathyroidism: Standards and Guidelines For Diagnosis and Management in Canada"],"prefix":"10.1016","volume":"9","member":"78","reference":[{"key":"10.4158\/EP.9.5.400_bb0005","first-page":"184","article-title":"Primary hyperparathyroidism: pathophysiology and impact on bone","volume":"63","author":"Khan","year":"2000","journal-title":"CMAJ."},{"issue":"Suppl 2","key":"10.4158\/EP.9.5.400_bb0010","first-page":"S1","volume":"6","author":"Proceedings of the NIH consensus development conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29-31, 1990","year":"1991","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0015","unstructured":"Bilezikian JP, Potts JT Jr, Fuleihan G-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res. 2002;17(Suppl 2):N2-N11."},{"key":"10.4158\/EP.9.5.400_bb0020","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Potts JT Jr, Fuleihan G-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361.","DOI":"10.1210\/jc.2002-021370"},{"key":"10.4158\/EP.9.5.400_bb0025","series-title":"The Parathyroids","first-page":"157","article-title":"Advances in immunoassays for parathyroid hormone","author":"Nussbaum","year":"1994"},{"key":"10.4158\/EP.9.5.400_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem."},{"key":"10.4158\/EP.9.5.400_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0040","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1359\/jbmr.1997.12.5.856","article-title":"Primary hyperparathyroidism: still evolving [erratum in J Bone Miner Res. 1997;12:1538]?","volume":"12","author":"Silverberg","year":"1997","journal-title":"J Bone Miner Res."},{"issue":"Suppl 2","key":"10.4158\/EP.9.5.400_bb0045","first-page":"N51","article-title":"Familial benign hypocalciuric hypercalcemia","volume":"17","author":"Fuleihan","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4158\/EP.6.5.385","article-title":"Skeletal effects of primary hyperparathyroidism","volume":"6","author":"Syed","year":"2000","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.9.5.400_bb0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [erratum in N Engl J Med. 2000;342:144]","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.9.5.400_bb0060","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ."},{"key":"10.4158\/EP.9.5.400_bb0065","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res."},{"issue":"Suppl","key":"10.4158\/EP.9.5.400_bb0070","first-page":"S166","article-title":"Three dimensional assessment of trabecular architecture in mild primary hyperparathyroidism [abstract]","volume":"17","author":"Dempster","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0075","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","article-title":"Patientbased surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism","volume":"26","author":"Pasieka","year":"2002","journal-title":"World J Surg."},{"key":"10.4158\/EP.9.5.400_bb0080","unstructured":"Taillefer R. Parathyroid scintigraphy in nuclear oncology: diagnosis and therapy. Editors: Khalkhali I, Maublant J, Goldsmith S, eds. Philadelphia: Lippincott Williams & Wilkins, 200: 221-244."},{"issue":"10","key":"10.4158\/EP.9.5.400_bb0085","first-page":"1758","article-title":"99mTc-sestamibi parathyroid scintigraphy","volume":"36","author":"Taillefer","year":"1995","journal-title":"Nucl Med Annu."},{"key":"10.4158\/EP.9.5.400_bb0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.218.3.r01fe38783","article-title":"Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism","volume":"218","author":"Gotway","year":"2001","journal-title":"Radiology."},{"key":"10.4158\/EP.9.5.400_bb0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0039-6060(99)70053-X","article-title":"The evolution of parathyroidectomy failures [with discussion]","volume":"126","author":"Boggs","year":"1999","journal-title":"Surgery."},{"key":"10.4158\/EP.9.5.400_bb0100","first-page":"693","article-title":"Unilateral parathyroid exploration [with discussion]","volume":"64","author":"Vogel","year":"1998","journal-title":"Am Surg."},{"key":"10.4158\/EP.9.5.400_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00000658-200009000-00005","article-title":"One hundred consecutive minimally invasive parathyroid explorations","volume":"232","author":"Udelsman","year":"2000","journal-title":"Ann Surg."},{"key":"10.4158\/EP.9.5.400_bb0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1365-2168.1999.01295.x","article-title":"Endoscopically assisted, minimally invasive parathyroidectomy","volume":"86","author":"Gauger","year":"1999","journal-title":"Br J Surg."},{"key":"10.4158\/EP.9.5.400_bb0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1067\/msy.2099.102269","article-title":"Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study [with discussion]","volume":"126","author":"Miccoli","year":"1999","journal-title":"Surgery."},{"key":"10.4158\/EP.9.5.400_bb0120","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1067\/msy.2099.101433","article-title":"Outpatient minimally invasive parathyroidectomy: a combination of sestamibi- SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay [with discussion]","volume":"126","author":"Chen","year":"1999","journal-title":"Surgery."},{"key":"10.4158\/EP.9.5.400_bb0125","doi-asserted-by":"crossref","unstructured":"Kao PC, van Heerden JA, Taylor RL. Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay. Mayo Clin Proc. 1994;69:532-537.","DOI":"10.1016\/S0025-6196(12)62243-5"},{"key":"10.4158\/EP.9.5.400_bb0130","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/clinchem\/42.9.1498","article-title":"Rapid PTH assay by simple modification of Nichols intact PTH-parathyroid hormone assay kit [letter]","volume":"42","author":"Fleetwood","year":"1996","journal-title":"Clin Chem."},{"key":"10.4158\/EP.9.5.400_bb0135","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1046\/j.1365-2168.1998.00824.x","article-title":"Measurement of parathyroid hormone in patients with primary hyperparathyroidism undergoing first and reoperative surgery","volume":"85","author":"Bergenfelz","year":"1998","journal-title":"Br J Surg."},{"key":"10.4158\/EP.9.5.400_bb0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00000658-199906000-00015","article-title":"Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay [with discussion]","volume":"229","author":"Irvin","year":"1999","journal-title":"Ann Surg."},{"key":"10.4158\/EP.9.5.400_bb0145","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1067\/msy.2001.118376","article-title":"Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost-effectiveness study","volume":"130","author":"Agarwal","year":"2001","journal-title":"Surgery."},{"key":"10.4158\/EP.9.5.400_bb0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1067\/msy.2099.102044","article-title":"Is sestamibiguided parathyroidectomy really cost-effective [with discussion]?","volume":"126","author":"Greene","year":"1999","journal-title":"Surgery."},{"key":"10.4158\/EP.9.5.400_bb0155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism: a randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.9.5.400_bb0165","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.160.14.2161","article-title":"Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women","volume":"160","author":"Orr-Walker","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.9.5.400_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.5650090410","article-title":"Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy","volume":"9","author":"McDermott","year":"1994","journal-title":"J Bone Miner Res."},{"issue":"Suppl 1","key":"10.4158\/EP.9.5.400_bb0175","first-page":"S165","article-title":"A doubleblind randomized placebo-controlled trial of alendronate in primary hyperparathyroidism [abstract]","volume":"17","author":"Khan","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0185","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00019616-200111000-00006","article-title":"Alendronate therapy of primary hyperparathyroidism","volume":"11","author":"El Hassani","year":"2001","journal-title":"Endocrinologist."},{"key":"10.4158\/EP.9.5.400_bb0190","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","article-title":"Alendronate in the treatment of primary hyperparathyroidism- related osteoporosis: a 2-year study","volume":"87","author":"Parker","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.9.5.400_bb0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 1","key":"10.4158\/EP.9.5.400_bb0200","first-page":"SU467","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in primary hyperparathyroidism [abstract]","volume":"17","author":"Rubin","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.9.5.400_bb0210","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Shortterm inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism","volume":"337","author":"Silverberg","year":"1997","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.9.5.400_bb0215","unstructured":"Peacock M, Bilezikian JP, Turner SA, et al. Long term treatment with the calcimimetic AMG 073 in patients with primary hyperparathyroidism (PHPT). In: Program and abstracts of the 84th Annual Meeting of the Endocrine Society, 2002, San Francisco, CA, p 92."},{"key":"10.4158\/EP.9.5.400_bb0220","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20408389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20408389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/CHAQ5C6QFLU3Y32T.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:44:12Z","timestamp":1761515052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20408389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S1530891X20408389"],"URL":"https:\/\/doi.org\/10.4158\/ep.9.5.400","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymptomatic Primary Hyperparathyroidism: Standards and Guidelines For Diagnosis and Management in Canada","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.9.5.400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}